Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China-Reference-Cited by-同舟云学术

Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China

Published:2019-10 Issue:10 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Jia Xueyang¹²,Ren Hongyu¹,Nie Xudong¹,Li Yinan¹,Li Jianguo²,Qin Tian¹³

Affiliation:

1. State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China

2. Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China

3. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China

Abstract

Legionnaires’ disease, caused by Legionella pneumophila , has been treated primarily with antibiotics. However, few reports have been published on antibiotic-resistant Legionella in China. Our aim was to determine the azithromycin resistance mechanism of L. pneumophila serogroup 1 in China.

Funder

National Science Foundation of China

Science Foundation for the State Key Laboratory for Infectious Disease Prevention and Control of China

Priority Project on Infectious Disease Control and Prevention of the Ministry of Science and Technology of the People's Republic of China

Shenzhen Science and Technology Innovation Commission | Sanming Project of Medicine in Shenzhen

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00768-19

Reference27 articles.